Hosted on MSN
Topical treatment offers relief from painful skin rash caused by targeted cancer therapy
Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...
A research team from the UCLA Health Jonsson Comprehensive Cancer Center, the University of Texas MD Anderson Cancer Center, and collaborators have demonstrated that a novel topical BRAF inhibitor gel ...
An investigational immunomodulator gel significantly improved malodor and measures related to pain and quality of life for ...
Hosted on MSN
Topical gel relieves painful skin rash side effect caused by targeted therapy for colorectal cancer
A new topical gel called LUT014 successfully reduced the severity of a painful acne‐like rash that commonly occurs as a side effect of targeted therapy with epidermal growth factor receptor (EGFR) ...
Please provide your email address to receive an email when new articles are posted on . Phase 2a interim data show 100% of patients achieving the primary endpoint of skin toxicity improvement. Also, ...
New research reveals how calcipotriol-plus–5-FU therapy activates immune pathways to prevent squamous cell carcinoma with long-lasting protection. Study: T helper 2 cell–directed immunotherapy ...
Novel treatment allowed patients with colorectal cancer to successfully continue taking their cancer treatment with improved quality of life Acne-like skin rash is a common side effect from colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback